Glucagon-like peptide-1 (GLP-1) peptides have emerged as a compelling therapeutic target for managing metabolic syndromes. These naturally occurring hormones are secreted by the gut in response to meal intake, https://hubwebsites.com/story21881432/unveiling-the-therapeutic-potential-of-glp-1-peptides